Skip to main content
. 2020 Dec 16;26(2):e230–e240. doi: 10.1002/onco.13581
Name NC/NA 1 2 3 4 5 All grades
Alopecia 60% 11% 29% 0% 0% 0% 40%
Fatigue 68% 7% 21% 4% 0% 0% 32%
Nausea 75% 7% 18% 0% 0% 0% 25%
Neutrophil count decreased 71% 0% 0% 18% 11% 0% 29%
Paresthesia 96% 0% 4% 0% 0% 0% 4%
Skin and subcutaneous tissue disorders 93% 0% 7% 0% 0% 0% 7%
Constipation 92% 4% 4% 0% 0% 0% 8%
Mucositis oral 82% 4% 14% 0% 0% 0% 18%
Myalgia 81% 11% 4% 4% 0% 0% 19%
Diarrhea 89% 4% 7% 0% 0% 0% 11%
Fever 89% 4% 7% 0% 0% 0% 11%
Vomiting 92% 0% 4% 4% 0% 0% 8%
Alanine aminotransferase increased 96% 0% 0% 4% 0% 0% 4%
Nasal congestion 100% 0% 0% 0% 0% 0% 0%
Pain 96% 0% 4% 0% 0% 0% 4%
Rash acneiform 100% 0% 0% 0% 0% 0% 0%
White blood cell decreased 96% 0% 0% 0% 4% 0% 4%
Abdominal pain 96% 4% 0% 0% 0% 0% 4%
Arthralgia 100% 0% 0% 0% 0% 0% 0%
Aspartate aminotransferase increased 96% 0% 0% 4% 0% 0% 4%
Bladder infection 96% 0% 4% 0% 0% 0% 4%
Dizziness 96% 0% 0% 4% 0% 0% 4%
Edema limbs 100% 0% 0% 0% 0% 0% 0%
Headache 96% 0% 4% 0% 0% 0% 4%
Hyperglycemia 96% 4% 0% 0% 0% 0% 4%
Infections and infestations 96% 0% 4% 0% 0% 0% 4%
Insomnia 100% 0% 0% 0% 0% 0% 0%
Left ventricular systolic dysfunction 100% 0% 0% 0% 0% 0% 0%
Memory impairment 100% 0% 0% 0% 0% 0% 0%
Nail loss 100% 0% 0% 0% 0% 0% 0%
Neutropenic sepsis 96% 0% 0% 0% 0% 4% 4%
Skin infection 100% 0% 0% 0% 0% 0% 0%
Vaginal infection 96% 0% 4% 0% 0% 0% 4%
Vaginal inflammation 100% 0% 0% 0% 0% 0% 0%

See also Tables 2, 3, 4 below.

Abbreviation: NC/NA, no change from baseline/no adverse event.